Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06535178 · ClinicalTrials.gov registry record · NA

The Influence of Sleep on Cardiovascular Outcomes

A NA study of Pain and Circadian Rhythm, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06535178 is a NA study of Pain and Circadian Rhythm that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 30 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06535178, a NA study of Pain and Circadian Rhythm, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to identify the effects of sleep regularity on cardiovascular regulatory mechanisms. The investigators are hoping to discover if improving the regularity of sleep timing will improve metabolic and vascular health markers. The protocol is a 12-week prospective cohort study that includes both field and in-laboratory data collection in ostensibly healthy male and female adults, aged 18-40years. We will also have a sub-group of individuals with chronic pain to examine the effects of sleep regularity on pain outcomes.

Interventions

  • BEHAVIORAL Sleep Regularity Group

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-07-01
Est. Completion 2026-09-30
Phase NA

What the Registry Record Tells You About NCT06535178

The ClinicalTrials.gov registry entry for NCT06535178 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (90% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Sleep Regularity Group is the first listed.

NCT06535178 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06535178 about?

NCT06535178 is a clinical study titled "The Influence of Sleep on Cardiovascular Outcomes". The goal of this study is to identify the effects of sleep regularity on cardiovascular regulatory mechanisms. The investigators are hoping to discover if improving the regularity of sleep timing will improve metabolic and vascular health markers. The protocol is a 12-week prospective cohort study t...

What is the current status of trial NCT06535178?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-07-01. Estimated completion is 2026-09-30.

What conditions does trial NCT06535178 study?

This clinical trial studies the following conditions: Pain, Circadian Rhythm, Cardiometabolic Health, Vascular Health.

What interventions are being tested in trial NCT06535178?

The interventions under investigation include: Sleep Regularity Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06535178?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06535178 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.